Los Angeles, US, May 6 (efe-epa).- Madonna clarified Wednesday that she suffered from COVID-19 at the beginning of March, during the end of her tour in Paris, and that for this reason antibodies had been detected in her system, as media outlets speculated that the American singer was sick.
Last week, the artist made news after she confirmed in a video that she had tested positive for coronavirus antibodies and added that she was planning to go for a “long drive” and, “breathe in COVID-19 air.”
This led to some followers and media outlets describing her words as reckless and speculating that she was currently suffering from COVID-19.
Madonna took to Instagram Wednesday to clarify her current state of health and announce that she had donated $1.1 million to research into finding the cure for the virus and the development of a vaccine to fight the infectious disease.
“When you test positive for anti-bodies it means you HAD the virus which I clearly did as I was sick at the end of my tour in Paris over 7 weeks ago,” said the “Material Girl” singer.
The 61-year-old artist added that many of the team members who accompanied her on tour were also sick during the same period.
“We all thought we had a very bad flu. Thank God we are all healthy and well now,” she said, adding, “Hope that clears things up for the band wagon jumpers!! Knowledge is Power!”
This week, Madonna was one of the donors participating in an international conference organized by the European Union for the development of new diagnostic methods, treatments and a universal vaccine against the novel coronavirus, in which her country, the United States, did not participate.
The fund collection came close to the goal of $8 billion, of which around 53 percent will be spent on future vaccines, 26 percent on research into new medicines and 20 percent on developing tests.
As well as contributions from countries and international agencies, personalities such as Bill and Melinda Gates and Portuguese soccer manager Jose Mourinho also participated in the initiative. EFE-EPA